Hypertrophic Cardiomyopathy

Overview

4.5 out of 5 (52 Reviews)

Credits

2.00

Post Assessment Questions

11

Start Date

1 Sep 2023

Last Review Date

14 Apr 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

120 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant cardiac myocyte disease caused by mutations in sarcomere protein genes encoding for elements of the contractile machinery of the heart. Characteristic cardiac structural changes include increased left ventricular wall thickness causing dynamic left ventricular outflow obstruction, diastolic dysfunction, myocardial ischemia, arrhythmias, autonomic dysfunction, and mitral regurgitation. In the United States, HCM is the most common identifiable cause of sudden cardiac death in healthy people aged younger than 35, including well-trained athletes. About 60% of patients with HCM have a known gene mutation of the sarcomere or sarcomere-related genes, and obtaining a detailed family history is crucial to help in risk stratification for affected patients. A comprehensive patient history and thorough physical exam can also help identify patients at risk of malignant arrhythmia. Early intervention through pharmacologic means, implantable cardiac-defibrillator placement, and surgical intervention when warranted have greatly improved the survival rates of HCM in the last few decades.

This course is designed to provide healthcare professionals with comprehensive knowledge and updates on the diagnosis, management, and latest advancements in the understanding of HCM. The underlying mechanisms and genetic basis of HCM, including the molecular pathways involved in disease progression, are explored, and the diverse clinical presentations and diagnostic modalities of HCM are reviewed. Current therapeutic approaches and, emerging treatments and research are discussed. This activity also highlights the role of the interprofessional team, empowering healthcare professionals to deliver high-quality care and support to individuals affected by HCM, enhancing patient safety and satisfaction.


UAN: JA4008338-0000-23-948-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the clinical manifestations and risk factors associated with hypertrophic cardiomyopathy (HCM), including family history, physical exam findings, and diagnostic test results.

  • Select appropriate screening tools and protocols to identify individuals at risk for HCM, including genetic testing for sarcomere gene mutations and echocardiography for structural abnormalities.

  • Implement evidence-based management strategies for patients diagnosed with HCM, including pharmacologic interventions, implantable cardioverter-defibrillator placement, and surgical options when indicated.

  • Communicate with patients and their families about the diagnosis, prognosis, and treatment options for HCM to ensure understanding and shared decision-making.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 2.00 ACPE credit(s). (UAN: JA4008338-0000-23-948-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Christopher T. on 1/11/2021

cynthia z. on 2/25/2021

LIBERTY M. on 3/26/2021

Elyshia L. on 10/10/2021

Shea D. on 11/10/2021

Gayle W. on 6/14/2022

Dr.Ayodhyaprasad S. on 6/28/2022

Prabhat K. on 7/14/2022

Tracy K. on 11/13/2022

none

Stuart D. on 11/18/2022

Andrea C. on 12/12/2022

Michael K. on 1/16/2023

Casey R. on 5/23/2023

Gautam P. on 4/7/2023

James N. on 6/1/2023

Ajay P. on 6/5/2023

Laxmi S. on 6/8/2023

Thomas G. on 6/24/2023

MARIUS T. on 6/28/2023

Mergene T. on 8/1/2023

Grace A. on 8/13/2023

NISHA N. on 8/28/2023

Sonia L. on 9/6/2023

Lisa N. on 9/28/2023

Kacie B. on 10/6/2023

roxanna g. on 10/7/2023

Corey E. on 10/26/2023

Kimberly N. on 10/29/2023

John L. on 11/4/2023

Ehsan Q. on 11/10/2023

James B. on 11/18/2023

Donna P. on 11/22/2023

Jennifer S. on 11/29/2023

marc w. on 12/4/2023

Carly G. on 12/4/2023

Christopher M. on 12/6/2023

Colbert P. on 12/6/2023

Diego M. on 12/10/2023

Gary S. on 12/11/2023

Elizabeth W. on 12/13/2023

Jennifer S. on 12/24/2023

Paula R. on 12/28/2023

Timothy M. on 2/22/2024

Shepard W. on 2/24/2024

Alexander B. on 2/27/2024

Michelle W. on 3/5/2024

Raymond A. on 3/18/2024

Steven g. on 3/19/2024

julian S. on 3/24/2024

Hawabu S. on 3/25/2024

Pamela A. on 4/1/2024

Luis C. on 4/3/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

Single Activity

Take this single activity

$58 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user